Advertisement

Corrigendum

    Open AccessPublished:September 17, 2020DOI:https://doi.org/10.1016/j.oret.2020.09.009
        The authors of “Association between axial length and myopic maculopathy: the Hisayama study” (Ophthalmology Retina. 2019;3:867--873) would like to make the following corrections:
        The first sentence of the fourth paragraph of the Results section should read (correction in bold):
        Supplemental Table 2 (available at www.ophthalmologyretina.org) shows the characteristics of 74 participants with myopic maculopathy and its subtypes (diffuse chorioretinal atrophy [n = 37], patchy chorioretinal atrophy [n = 31], macular atrophy [n = 6], and plus lesions [n = 15]). The most prevalent subtype of myopic maculopathy was diffuse chorioretinal atrophy in men (60.0 %) and patchy choroidal atrophy in women (52.3%).
        Table 2 and Supplemental Table 2 are corrected below (corrections in bold):
        Table 2Association between Axial Length and Myopic Maculopathy in Right Eyes in the 2012 Hisayama Study
        Axial LengthP Value for Trend
        Quartile 1
        For men: quartile 1, <23.1 mm; quartile 2, 23.1--23.8 mm; quartile 3, 23.9--24.7 mm; and quartile 4, >24.7 mm. For women: quartile 1, <22.7 mm; quartile 2, 22.7--23.2 mm; quartile 3, 23.3--24.2 mm; and quartile 4, >24.3 mm.
        Quartile 2
        For men: quartile 1, <23.1 mm; quartile 2, 23.1--23.8 mm; quartile 3, 23.9--24.7 mm; and quartile 4, >24.7 mm. For women: quartile 1, <22.7 mm; quartile 2, 22.7--23.2 mm; quartile 3, 23.3--24.2 mm; and quartile 4, >24.3 mm.
        Quartile 3
        For men: quartile 1, <23.1 mm; quartile 2, 23.1--23.8 mm; quartile 3, 23.9--24.7 mm; and quartile 4, >24.7 mm. For women: quartile 1, <22.7 mm; quartile 2, 22.7--23.2 mm; quartile 3, 23.3--24.2 mm; and quartile 4, >24.3 mm.
        Quartile 4
        For men: quartile 1, <23.1 mm; quartile 2, 23.1--23.8 mm; quartile 3, 23.9--24.7 mm; and quartile 4, >24.7 mm. For women: quartile 1, <22.7 mm; quartile 2, 22.7--23.2 mm; quartile 3, 23.3--24.2 mm; and quartile 4, >24.3 mm.
        Men
         Range of axial length (mm)
        For men: quartile 1, <23.1 mm; quartile 2, 23.1--23.8 mm; quartile 3, 23.9--24.7 mm; and quartile 4, >24.7 mm. For women: quartile 1, <22.7 mm; quartile 2, 22.7--23.2 mm; quartile 3, 23.3--24.2 mm; and quartile 4, >24.3 mm.
        <23.123.1–23.823.9–24.6≥24.7
         No. of subjects305302313296
         No. of eyes with myopic maculopathy02523
         Crude OR (95% CI)1.00 (reference)4.91 (0.95–25.46)25.39 (5.95–108.46)
        P < 0.01 vs. the reference.
        0.10
         Adjusted OR (95% CI)
        Adjusted for age and body height.
        1.00 (reference)5.55 (1.07–28.76)
        P < 0.05 vs. the reference.
        39.99 (9.59–166.79)
        P < 0.01 vs. the reference.
        0.04
        Women
         Range of axial length (mm)
        Adjusted for age and body height.
        <22.722.7–23.223.3–24.2≥24.3
         No. of subjects378424365406
         No. of eyes with myopic maculopathy11537
         Crude OR (95% CI)1.00 (reference)6.29 (1.20–33.02)
        P < 0.05 vs. the reference.
        54.71 (11.78–254.09)
        P < 0.01 vs. the reference.
        <0.001
         Adjusted OR (95% CI)
        Adjusted for age and body height.
        1.00 (reference)9.62 (1.83–50.69)
        P < 0.05 vs. the reference.
        119.27 (26.92–528.42)
        P < 0.01 vs. the reference.
        <0.001
        CI = confidence interval; OR = odds ratio.
        The combination of quartile 1 and 2 groups was used as a reference group.
        For men: quartile 1, <23.1 mm; quartile 2, 23.1--23.8 mm; quartile 3, 23.9--24.7 mm; and quartile 4, >24.7 mm. For women: quartile 1, <22.7 mm; quartile 2, 22.7--23.2 mm; quartile 3, 23.3--24.2 mm; and quartile 4, >24.3 mm.
        Adjusted for age and body height.
        P < 0.01 vs. the reference.
        § P < 0.05 vs. the reference.
        The authors declare that these corrections do not change the results or conclusions of this paper.

        Supplementary Material

        Supplementary Table 2Characteristics of the subjects with myopic maculopathy and its subtypes in right eyes, the Hisayama Study, 2012
        TotalSubtypes of myopic macropathyPlus lesions
        Diffuse chorioretinal atrophyPatchy chorioretinal atrophyMacular atrophy
        Men
         Number of eyes, (%)30 (100.0)18 (60.0)8 (26.7)4 (13.3)6 (20.0)
         Age (years), mean ± SD69±1165±972±1464±1684
         Axial length (mm), median (IQR)26.2 (24.8 to 27.3)26.1 (25.0 to 26.6)27.2 (25.3 to 28.7)27.5 (24.0 to 31.5)25.7 (24.7 to 27.9)
         SE refraction (D), median (IQR)
        Subjects with a history of cataract surgery in the right eye were excluded.
        –3.75 (–7.38 to –2.13)–3.75 (−6.13 to –2.38)–6.25 (–8.94 to –2.69)–7.56 (–16.88 to 1.75)–1.13 (–3.43 to –0.74)
        Women
         Number of eyes (%)44 (100.0)19 (43.2)23 (52.3)2 (4.5)9 (20.5)
         Age (years), mean ± SD70±1070±869±1165±075±8
         Axial length (mm), median (IQR)26.5 (24.6, 27.9)24.8 (24.2 to 25.7)26.6 (24.9 to 27.8)27.9 (26.5 to 29.3)28.1 (26.7 to 30.3)
         SE refraction (D), median (IQR)
        Subjects with a history of cataract surgery in the right eye were excluded.
        –6.25 (–10.25 to –3.00)–3.69 (–9.00 to –1.69)–6.38 (–8.75 to –5.13)–8.88
        IQR is not shown because there were only two eyes with relevant subtypes.
        –10.25 (–14.63 to –2.50)
        mCNV, myopic neovascularization; SD, standard deviation; IQR, interquartile range; SE, spherical equivalent; D, diopter.
        Subjects with a history of cataract surgery in the right eye were excluded.
        IQR is not shown because there were only two eyes with relevant subtypes.

        Linked Article